| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0264-410X(95)80050-N |
| P698 | PubMed publication ID | 7571830 |
| P2093 | author name string | M Kane | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatitis B | Q6853 |
| P304 | page(s) | S47-9 | |
| P577 | publication date | 1995-01-01 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Global programme for control of hepatitis B infection | |
| P478 | volume | 13 Suppl 1 |
| Q45055696 | -Vaccination against hepatitis B-. |
| Q49334681 | A Diagnostic Laboratory-Based Study on Frequency and Distribution of Viral Hepatitis B and C Among Sudanese |
| Q80049574 | A controlled clinical trial comparing the safety and immunogenicity of a new adjuvanted hepatitis B vaccine with a standard hepatitis B vaccine |
| Q46770939 | A novel hepatitis B vaccination regimen for adolescents: two doses 12 months apart |
| Q34189153 | A prophylactic hepatitis B vaccine with a novel adjuvant system |
| Q38492566 | Analysis of differentially expressed genes and microRNAs in alcoholic liver disease |
| Q36388975 | Antibody response to revaccination among adult non-responders to primary Hepatitis B vaccination in China |
| Q40778973 | Antibody responses to preS components after immunization of children with low doses of BioHepB. |
| Q89691851 | Are men who have sex with men in Europe protected from hepatitis B? |
| Q36740003 | Assessment of Adherence to Prescribed Therapy in Patients with Chronic Hepatitis B. |
| Q50713573 | Assessment of cost-effectiveness of universal hepatitis B immunization in a low-income country with intermediate endemicity using a Markov model |
| Q26772343 | Association between hepatitis B and metabolic syndrome: Current state of the art |
| Q36680086 | Cancer prevention in HIV-infected populations |
| Q46158659 | Changes in Peripheral CD4+CD25high Regulatory T Cells in the Acute-on-Chronic Liver Failure Patients with Plasma Exchange Treatment |
| Q83826534 | Cimetidine augments Th1/Th2 dual polarized immune responses to recombinant HBV antigens |
| Q35071452 | Clinical and virological aspects of hepatitis B co-infection in individuals infected with human immunodeficiency virus type-1. |
| Q42365497 | Combating the wrath of viral hepatitis in India |
| Q34592952 | Comparison of three luminescent immunoassays for hepatitis B virus surface antigen quantification during the natural history of chronic hepatitis B virus infection |
| Q73358368 | Controlled release microparticles as a single dose hepatitis B vaccine: evaluation of immunogenicity in mice |
| Q43471631 | Decline of hepatitis B infection in Greece |
| Q54551790 | Development of the diagnostic immunoassay to detect anti-PreS1(21-47aa) antibody--a marker suggesting the health improvement of hepatitis B patients |
| Q42672355 | Differences in knowledge of hepatitis B among korean immigrants in two cities in the rocky mountain region |
| Q42145809 | Effect of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in lymphoma: a meta-analysis of published clinical trials and a decision tree addressing prolonged prophylaxis and maintenance |
| Q34456589 | Effectiveness of HBV Vaccination in Infants and Prediction of HBV Prevalence Trend under New Vaccination Plan: Findings of a Large-Scale Investigation |
| Q44444926 | Effects of interferon alpha therapy on the catalytic domains of the polymerase gene and basal core promoter, precore and core regions of hepatitis B virus |
| Q37631905 | Efficacy of double dose recombinant hepatitis B vaccination in chronic hepatitis C patients, compared to standard dose vaccination |
| Q80387916 | Efficacy of lamivudine therapy in elderly patients with chronic hepatitis B infection |
| Q38544189 | Emerging challenges in managing hepatitis B in HIV patients |
| Q35621655 | Epidemiology of hepatitis B in Europe and worldwide |
| Q37721884 | Evaluation of vaccination status against hepatitis B and HBsAg carriage among medical and paramedical staff of the Yaoundé Central Hospital, Cameroon |
| Q36841719 | Future prospectives for the management of chronic hepatitis B. |
| Q37233997 | Gastroenterology in developing countries: issues and advances |
| Q34749752 | Global control of hepatitis B virus infection. |
| Q36388338 | HBV epidemiology in Latin America |
| Q77093960 | Health outcomes and infectious disease control |
| Q84500535 | Hepatitis B (prevention) |
| Q57922923 | Hepatitis B Surface Antigen Seroprevalence among Prevaccine and Vaccine Era Children in Bangladesh |
| Q88946791 | Hepatitis B Vaccination - Protection with and without Birth Dose? |
| Q35039134 | Hepatitis B Virus Genotypes Distribution with HBsAg Positive in the North of Iran (Mazandaran) During 2011-2014. |
| Q41911606 | Hepatitis B Virus Infection: Emerging Challenges for the Armed Forces |
| Q34323219 | Hepatitis B and hepatitis C co-infection in patients with HIV. |
| Q73710579 | Hepatitis B component does not interfere with the immune response to diphtheria, tetanus and whole-cell Bordetella pertussis components of a quadrivalent (DTPw-HB) vaccine: a controlled trial in healthy infants |
| Q34737086 | Hepatitis B control in Europe by universal vaccination programmes: the situation in 2001. |
| Q37253592 | Hepatitis B infection is highly endemic in Uganda: findings from a national serosurvey. |
| Q34242773 | Hepatitis B sero-prevalence and risk behaviors among immigrant men in a population-based household survey in low-income neighborhoods of northern California. |
| Q35554552 | Hepatitis B vaccination in children with juvenile idiopathic arthritis. |
| Q79761793 | Hepatitis B vaccination in women healthcare workers: a seroepidemiological survey |
| Q33936155 | Hepatitis B vaccination schedules in genitourinary medicine clinics |
| Q81138096 | Hepatitis B vaccine in the EPI schedule |
| Q34229091 | Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines |
| Q37137539 | Hepatitis B virus (HBV)-specific short hairpin RNA is capable of reducing the formation of HBV covalently closed circular (CCC) DNA but has no effect on established CCC DNA in vitro |
| Q34068616 | Hepatitis B virus DNA level Among the Seropositive Afghan Immigrants, Southern Iran. |
| Q30235028 | Hepatitis B virus and its sexually transmitted infection - an update |
| Q36901776 | Hepatitis B virus genotypes and evolutionary markers in chronic HBsAG patients in Bujumbura |
| Q29036593 | Hepatitis B virus infection among American patients with chronic hepatitis C virus infection: Prevalence, racial/ethnic differences, and viral interactions |
| Q35529989 | Hepatitis B virus infection among Chinese residents in the United Kingdom |
| Q44010172 | Hepatitis B virus infection and B-cell non-Hodgkin's lymphoma in a hepatitis B endemic area: a case-control study |
| Q41708794 | Hepatitis B virus infection and decreased risk of stroke: a meta-analysis |
| Q47164631 | Hepatitis B virus infection and the risk of nonalcoholic fatty liver disease: a meta-analysis |
| Q37831695 | Hepatitis B virus infection, its sequelae, and prevention by vaccination |
| Q37729188 | Hepatitis B-specific T helper cell responses in uninfected infants born to HBsAg+/HBeAg- mothers |
| Q34134967 | Hepatocellular carcinoma in the world and the middle East |
| Q27489394 | Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis |
| Q44696245 | Hospitalizations due to hepatitis A, B and C in Austria 1996-1998 |
| Q36388375 | Immune system and hepatitis B virus infection |
| Q33858661 | Immunogenicity in humans of an edible vaccine for hepatitis B. |
| Q52648926 | Immunogenicity, safety, and tolerability of a recombinant hepatitis B vaccine manufactured by a modified process in healthy young Japanese adults |
| Q36375893 | Immunotherapeutic relief from persistent infections and amyloid disorders. |
| Q36279736 | Improving Hepatitis B Vaccine Efficacy in End-Stage Renal Diseases Patients and Role of Adjuvants |
| Q34997379 | Inactivated ORF virus shows antifibrotic activity and inhibits human hepatitis B virus (HBV) and hepatitis C virus (HCV) replication in preclinical models |
| Q33750371 | Interactions between hepatitis B virus infection and exposure to aflatoxins in the development of hepatocellular carcinoma: a molecular epidemiological approach |
| Q44706273 | Intrahepatic CD8 T-lymphocytes and HBV core expression in relation to response to antiviral therapy for chronic hepatitis B patients |
| Q84596995 | Intrahepatic levels of PD-1/PD-L correlate with liver inflammation in chronic hepatitis B |
| Q34412410 | Is Universal HBV Vaccination of Healthcare Workers a Relevant Strategy in Developing Endemic Countries? The Case of a University Hospital in Niger |
| Q37879194 | Is infection control an academic study? |
| Q44230423 | Is there a causal link between hepatitis B vaccination and multiple sclerosis? |
| Q45956421 | Levamisole is a potential facilitator for the activation of Th1 responses of the subunit HBV vaccination. |
| Q36453672 | Lower Viral Response to Pegylated Interferon Alpha 2a Treatment of Chronic Hepatitis B in Roma People in Eastern Slovakia |
| Q33678323 | Lower than expected hepatitis B virus infection prevalence among first generation Koreans in the U.S.: results of HBV screening in the Southern California Inland Empire |
| Q34584886 | Management of chronic hepatitis B and C virus infections |
| Q35635637 | Management of hepatitis B in developing countries |
| Q45253427 | Modeling the adaptive immune response in HBV infection |
| Q84735929 | Multicentre evaluation of the Elecsys hepatitis B surface antigen II assay for detection of HBsAg in comparison with other commercially available assays |
| Q73520258 | Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B |
| Q35026531 | New approaches in the management of chronic hepatitis B: role of tenofovir. |
| Q47558368 | Pathogenesis of Non-Zika Congenital Viral Infections |
| Q34450653 | Pegylated interferon α-2b up-regulates specific CD8+ T cells in patients with chronic hepatitis B |
| Q35621758 | Perspectives of public health: present and foreseen impact of vaccination on the epidemiology of hepatitis B. |
| Q47954925 | Preoperative vaccination for HBV at Polish hospitals as a possible public health tool to limit the spread of the epidemic: a cross-sectional study |
| Q34725473 | Prevalence and genotypes of hepatitis B virus infection in patients underwent coronary angiography and coronary artery bypass grafting in mazandaran heart center, sari, iran. |
| Q34636480 | Prevalence of hepatitis B surface antigen (HBsAg) and its risk factors among individuals visiting Goba General Hospital, South East Ethiopia, 2012. |
| Q37390442 | Prevalence of occult hepatitis B amongst Indian human immunodeficiency virus type 1 infected individuals-a pilot study. |
| Q45731967 | Prevalence, risk factors and evaluation of a screening strategy for chronic hepatitis C and B virus infections in healthy company employees |
| Q34737132 | Progress in the prevention and control of viral hepatitis type B: closing remarks |
| Q44193677 | Protective efficacy of hepatitis B vaccine without HBIG in infants of HBeAg-positive carrier mothers in Thailand |
| Q37450812 | Randomized controlled study investigating viral suppression and serological response following pre-S1/pre-S2/S vaccine therapy combined with lamivudine treatment in HBeAg-positive patients with chronic hepatitis B. |
| Q35001053 | Rebound of hepatitis B virus replication in HepG2 cells after cessation of antiviral treatment |
| Q26777516 | Recent advances in vaccination of non-responders to standard dose hepatitis B virus vaccine |
| Q33211869 | Reduced hepatitis B virus (HBV)-specific CD4+ T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapy |
| Q30356277 | Sense and the science of childhood immunization: can we achieve more with less? |
| Q34719828 | Sensitivities of four new commercial hepatitis B virus surface antigen (HBsAg) assays in detection of HBsAg mutant forms |
| Q33619872 | Sero-prevalence and risk factors for hepatitis B virus infection among health care workers in a tertiary hospital in Uganda |
| Q55517776 | Sero-prevalence of hepatitis B virus infection and associated factors among health care workers and medical waste handlers in primary hospitals of North-west Ethiopia. |
| Q33866297 | Seroprevalence and genotyping of hepatitis B, hepatitis C and HIV among healthy population and Turkish soldiers in Northern Cyprus. |
| Q34134536 | Seroprevalence of hepatitis B and C viruses among medical waste handlers at Gondar town Health institutions, Northwest Ethiopia |
| Q47108717 | Seroprevalence of hepatitis B, C and D viral among hemodialysis patients in Tehran |
| Q24816554 | Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B. |
| Q43977371 | Study of hepatitis B virus replication and infection by other hepatitis viruses in patients with chronic hepatitis B virus infection |
| Q39483471 | Synthesis and biological evaluation of Matijing-Su derivatives as potent anti-HBV agents |
| Q37256021 | T cell responses to hepatitis B surface antigen are detectable in non-vaccinated individuals |
| Q33703997 | Targeted hepatitis B vaccination--a cost effective immunisation strategy for the UK? |
| Q40534566 | The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa |
| Q45736724 | The effect of introduction of universal childhood hepatitis B immunization in South Africa on the prevalence of serologically negative hepatitis B virus infection and the selection of immune escape variants. |
| Q78424586 | The immunogenicity and reactogenicity profile of a candidate hepatitis B vaccine in an adult vaccine non-responder population |
| Q35200980 | The place of accelerated schedules for hepatitis A and B vaccinations |
| Q37021822 | Therapeutic strategies in the management of patients with chronic hepatitis B virus infection. |
| Q35099082 | Transition of care between paediatric and adult gastroenterology. Chronic viral hepatitis |
| Q56896375 | Viral hepatitis in hemodialysis: An update |
| Q33800048 | Vitamins in the treatment of chronic viral hepatitis. |
| Q73466751 | Who needs vaccination against hepatitis viruses? |
| Q43556048 | World-wide epidemiology of hepatitis B |
| Q77329831 | [Economic evaluation of various hepatitis B vaccination strategies in children and adolescents] |
| Q81703415 | [Hepatitis B vaccine after the 2003 consensus conference] |
| Q79820272 | [Vaccination against hepatitis B virus: ANAES and INSERM experts take a view] |
| Q73801575 | [Vaccination in France] |
Search more.